cft

Irritable Bowel Syndrome Treatment Market 2022-30 Explosive Trends at CAGR of 8.7%

In a recent research report by Market Research Community, the irritable bowel syndrome treatment market is expected to surpass USD 7.63 by the year 2030, from USD 3.60 Billion in 2021.


user

jiya pande

2 months ago | 3 min read

"Irritable Bowel Syndrome Treatment Market Overview:

In a recent research report by Market Research Community, the irritable bowel syndrome treatment market is expected to surpass USD 7.63 by the year 2030, from USD 3.60 Billion in 2021.

A digestive tract illness called irritable bowel syndrome is characterized by abdominal pain and irregular stool movements. It interferes with the way that intestinal muscular linings normally convey food through the digestive system. Irritable bowel syndrome can be classified as moderate or severe depending on the symptoms. Constipation, diarrhea, mucus in the stool, cramping, abdominal pain, bloating, and gas are some of these symptoms. Irritable bowel syndrome's exact cause is unknown, however, it is known to be related to greater awareness of body processes and irregular gastrointestinal tract motions.

 

Request Sample Report @ https://marketresearchcommunity.com/sample-request/?rid=834

Top Key Players of the Irritable Bowel Syndrome Treatment Market:Ironwood Pharmaceuticals, Inc.; Allergan; Astellas Pharma, Inc.; Takeda Pharmaceutical Company Limited AstraZeneca; Sebela Pharmaceuticals Inc.; Synergy Pharmaceuticals In. Bausch Health; Synthetic Biologics, Inc.; and Ardelyx.

Type Covered in This Report Are:IBS-CIBS-D

On the Basis of Products:XifaxanLinzess/ConstellaViberziAmitizaOthers

Regional Analysis:North America– (U.S., Canada, Mexico)Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe)Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific)Latin America- (Brazil, Argentina, Chile, Rest of Latin America)Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA)

Request for Customize Irritable Bowel Syndrome Treatment Report@ https://marketresearchcommunity.com/customise-report/?rid=834

The negative effects of the medications are one of the main barriers to the expansion of the global market for IBS treatments. For instance, the mixed mu-opioid receptor agonist eluxadoline, which is used to treat irritable bowel syndrome with diarrhea, can result in pancreatitis, a dangerous and more frequent pancreatic inflammation in some people.

Throughout the forecast period, the Linzess/Constella category is anticipated to develop at the fastest rate. In the United States, Linzess is marketed by Ironwood and Allergan, and Constella is marketed by Allergan in Europe. Astellas and AstraZeneca have the exclusive rights to create and market linaclotide as Linzess in Japan and China, respectively.

Moreover, owing to the increasing prevalence of irritable bowel syndrome increased knowledge of its treatment, and increased use of irritable bowel syndrome treatment products, Asia-Pacific offers lucrative prospects for key participants in the market for its treatment. Additionally, the development of the R&D sector, the expansion of healthcare reforms, and improvements in the healthcare infrastructure together with technological developments in the industry all contribute to the market's expansion.

The irritable bowel syndrome treatment market is projected to grow at a significant pace reaching a CAGR of approximately 8.7%, over the forecast period of 2022–2030, despite a considerable fall in Type sales during the initial phase of pandemic spread and lockdown restrictions imposed globally.

The study is consolidated into major segments and further into sub-segments, such as by Type (IBS-C, IBS-D) Product (XifaxanLinzess/Constella, Viberzi, Amitiza, Others) to forecast the market size by value; also includes the analysis of past market dynamics from 2016 – 2021, considering 2021 as the base year.

Get Full Report @ https://marketresearchcommunity.com/irritable-bowel-syndrome-treatment-market/

The research provides answers to the following key questions:

  • What is the expected growth rate of the Irritable Bowel Syndrome Treatment Market? What will be the market size for the forecast period, 2022 - 2030?
  • What are the major driving forces responsible for transforming the trajectory of the industry?
  • Who are major vendors dominating the Irritable Bowel Syndrome Treatment industry across different regions? What are their winning strategies to stay ahead in the competition?
  • What are the market trends business owners can rely upon in the coming years?
  • What are the threats and challenges expected to restrict the progress of the industry across different countries?
  • What are the key opportunities that business owners can bank on for the forecast period, 2022 - 2030?

Contact:
Market Research Community
+44-20-8133-9198
sales@marketresearchcommunity.com

Market Research Community is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domain. The industry provides consulting services, syndicated research reports, and customized research reports."

Upvote


user
Created by

jiya pande


people
Post

Upvote

Downvote

Comment

Bookmark

Share


Related Articles